FULZERASIB

Clinical trials for FULZERASIB explained in plain language.

Never miss a new study

Get alerted when new FULZERASIB trials appear

Sign up with your email to follow new studies for FULZERASIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Chemo-Free combo shows promise for Hard-to-Treat colorectal cancer

Disease control Recruiting now

This phase 2 trial tests two drugs, fulzerasib and cetuximab N01, given before surgery to people with a specific genetic subtype (KRAS G12C mutation) of locally advanced colorectal cancer. The goal is to shrink tumors and improve surgical outcomes without using chemotherapy. Fort…

Matched conditions: FULZERASIB

Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control

Last updated Jun 27, 2026 12:31 UTC

FULZERASIB

Get alerted when new FULZERASIB trials appear

Chemo-Free combo shows promise for Hard-to-Treat colorectal cancer